Anecortave acetate clinical trials
How each study uses anecortave acetate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
26 studies that test it; most in 2002 (5)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2000 | 1 |
| 2002 | 5 |
| 2003 | 3 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 3 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 17 · Other 10
Alcon Research (17) · Manhattan Eye, Ear & Throat Hospital (8) · Texas Retina Associates (1) · Cornea Research Foundation of America (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses anecortave acetate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 27
- Anecortave Acetate Injection to Treat Steroid-responsive Intraocular Pressure Increase in Cornea Transplant PatientsTerminatedNot applicableCornea Research Foundation of AmericaNCT00884039Written as anecortave acetateHow we know
- Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMDCompletedPhase 3Alcon ResearchNCT00041483Written as Anecortave Acetate 15 mg sterile suspensionHow we know
- Open-Label Posterior Juxtascleral Injections of Anecortave Acetate 15mg Dose for Long Term Use in Patients With AMDTerminatedPhase 3Alcon ResearchNCT00065728Written as Anecortave Acetate (AL-3789) Sterile Suspension, 30 mg/mLHow we know
- A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular HypertensionTerminatedPhase 2Alcon ResearchNCT00788541Written as Anecortave Acetate Sterile Suspension, 60 mg/MLHow we know
- An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMDCompletedPhase 3Alcon ResearchNCT00058994Written as anecortave acetateHow we know
- 24 Hour IOP Lowering Efficacy of AL-3789CompletedPhase 2Alcon ResearchNCT00643669Written as AL-3789 Sterile SuspensionHow we know
- Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) ElevationCompletedPhase 2Alcon ResearchNCT00315640Written as Anecortave Acetate Sterile Suspension, 60 mg/mLHow we know
- Anecortave Acetate in Subfoveal Choroidal Neovascularization (CNV) Due to Wet Age-Related Macular Degeneration (AMD)CompletedPhase 3Alcon ResearchNCT00051129Written as Anecortave Acetate 15 mg sterile suspensionHow we know
- Anecortave Acetate Safety in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedPhase 2/3Alcon ResearchNCT00691717Written as Anecortave Acetate Sterile Suspension, 30 mg/mLHow we know
- Anecortave Acetate in Patients With Open-angle GlaucomaCompletedPhase 2Alcon ResearchNCT00320203Written as Anecortave Acetate Sterile Suspension, 30 mg/mLHow we know
- Safety and Efficacy of Anecortave Acetate in Patients With Open-Angle GlaucomaCompletedPhase 2Alcon ResearchNCT00451152Written as Anecortave Acetate Sterile Suspension, 30 mg/mLHow we know
- Anecortave Acetate in Patients With Exudative Age-related Macular Degeneration (AMD)CompletedPhase 3Alcon ResearchNCT00299507Written as Anecortave Acetate Sterile Suspension, 30 mg/mLHow we know
- Anecortave Acetate Risk Reduction Trial (AART)TerminatedPhase 3Alcon ResearchNCT00332657Written as Anecortave Acetate Sterile Suspension, 30 mg/mLHow we know
- Anecortave Acetate Risk-Reduction Trial (AART)TerminatedPhase 3Alcon ResearchNCT00333216Written as Anecortave Acetate Sterile Suspension, 30 mg/mLHow we know
- Anecortave Acetate Risk-Reduction Trial (AART)TerminatedPhase 3Alcon ResearchNCT00307398Written as Anecortave Acetate (AL-3789) sterile suspension, 15 mg or 30 mgHow we know
- Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave AcetateCompletedPhase 1/2Manhattan Eye, Ear & Throat HospitalNCT00489840Written as Anecortave Acetate Sterile suspension 15 mgHow we know
- Study of the Combination of Anecortave Acetate and Triamcinolone Acetonide for the Treatment of Exudative Age-Related Macular Degeneration (AMD)CompletedPhase 1Manhattan Eye, Ear & Throat HospitalNCT00211419Written as Anecortave Acetate 15 mgHow we know
- Treatment of Congenital Telangiectasia (Coat's Disease) With Open-label Anecortave Acetate (15mg.)CompletedPhase 2Manhattan Eye, Ear & Throat HospitalNCT00211315Written as anecortave acetateHow we know
- Prophylactic Anecortave Acetate in Patients With a Retisert ImplantCompletedPhase 1Texas Retina AssociatesNCT00570479Written as anecortave acetateHow we know
- A Multi-Dose Study With a Treatment for Open-Angle GlaucomaWithdrawnPhase 2/3Alcon ResearchNCT00705770Written as Anecortave AcetateHow we know
Codes
What other systems call anecortave acetate · ClinicalTrials.gg INT004291
- MeSH (NLM) C418047anecortave acetateOne source NLM
- UNII (FDA) Y0PC411K4TANECORTAVE ACETATEConfirmed FDA, NLM, Wikidata
- Wikidata Q4761567anecortave acetateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C171908Anecortave AcetateOne source FDA
- DrugBank DB05288One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C418047 | anecortave acetate | One source NLM |
| UNII (FDA) | Y0PC411K4T | ANECORTAVE ACETATE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q4761567 | anecortave acetate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C171908 | Anecortave Acetate | One source FDA |
| DrugBank | DB05288 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.